What is Structure Based Design?
Structure Based Design, Inc. (SBD) is a specialized biotechnology firm focused on advancing drug discovery through sophisticated scientific services. The company excels in Macromolecule X-ray Crystallography, Fragment-based Crystallographic Screening, and Protein Biochemistry. SBD provides a comprehensive suite of services, including crystal structure determination, protein manufacturing, and assay development, catering to pharmaceutical and biotechnology clients. Their expertise is crucial for clients seeking to develop novel therapeutic solutions and accelerate their R&D pipelines.
How much funding has Structure Based Design raised?
Structure Based Design has raised a total of $50K across 1 funding round:
Debt
$50K
Debt (2021): $50K with participation from PPP
What's next for Structure Based Design?
With significant backing at a Series B/C stage, Structure Based Design is poised for accelerated development and market expansion. The substantial expansion capital is expected to fuel advancements in their core service offerings, potentially leading to new technological integrations or service line enhancements. This strategic investment will likely bolster their capacity to support a growing roster of clients in the pharmaceutical and biotech sectors, reinforcing their position as a key player in the drug discovery ecosystem. Future growth may involve scaling operations, enhancing their proprietary technologies, and forging new strategic partnerships.
See full Structure Based Design company page
